Multiple Rising Dose Study of MK-6194 in Participants With Atopic

See also
Status	Clinical Trial	Phase
Completed	`NCT03563066` - Effect of Benralizumab in Atopic Dermatitis	Phase 2
Terminated	`NCT04086121` - A Study to Test the Long-term Safety of BI 655130 in Patients With Atopic Eczema Who Took Part in Study 1368-0032	Phase 2
Recruiting	`NCT04011215` - Wool Clothing for the Management of Childhood Atopic Dermatitis (DESSINE2)	N/A
Completed	`NCT04635072` - Stabilized Whole Rice Bran (SWRB) for Mild to Moderate Atopic Dermatitis	Early Phase 1
Completed	`NCT02916888` - A Study Comparing the Quality of Life of Patients in the Treatment of Eczema by Pediatric Generalists and Specialists	N/A
Completed	`NCT01945086` - A Study of Ustekinumab (STELARA®) in Adult Japanese Participants With Severe Atopic Dermatitis	Phase 2
Completed	`NCT00541255` - A Long-Term Examination of Asthma From Childhood Through Adolescence
Terminated	`NCT04990440` - A Study of Bermekimab for the Treatment of Adult Participants With Moderate-to-Severe Atopic Dermatitis	Phase 2
Completed	`NCT02900131` - Efficacy, Safety and Dose Finding Trial of Topical Jaungo Application in Atopic Dermatitis Patients	Phase 2
Completed	`NCT03568136` - Investigation of Efficacy of Secukinumab in Patients With Moderate to Serve Atopic Dermatitis	Phase 2
Recruiting	`NCT01631617` - Effects of Treatments on Atopic Dermatitis	Phase 2
Completed	`NCT03672383` - Functional Study to Investigate the Efficacy of a New Medical Device (Modified Diprobase Formulation)	N/A
Completed	`NCT03634345` - Drug Drug Interaction Study Evaluating the Effect of Fluvoxamine or Fluconazole on PK and Safety of PF-04965842.	Phase 1
Enrolling by invitation	`NCT04761978` - Efficacy and Tolerance of JAK Inhibitors in ATU for Atopic Dermatitis
Completed	`NCT03663673` - Effect of Different Skin Creams on TEWL	Phase 1
Recruiting	`NCT05177744` - Toxicity of Micro and Nano Plastics Combined With Environmental Contaminants on the Risk of Allergic Disease
Completed	`NCT03720470` - Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy	Phase 3
Completed	`NCT02637206` - Skin Irritation Study of GSK2894512 Cream	Phase 1
Completed	`NCT05544591` - Evaluation of 611 in Chinese Adults With Moderate to Severe Atopic Dermatitis	Phase 2
Completed	`NCT05094700` - A Study of a Polymeric Surfactant Technology Cleanser in Sensitive Skin Participants	N/A

NCT number	NCT05450198
Study type	Interventional
Source	Merck Sharp & Dohme LLC
Contact
Status	Completed
Phase	Phase 1
Start date	August 8, 2022
Completion date	May 22, 2024

Multiple Rising Dose Study of MK-6194 in Participants With Atopic Dermatitis (MK-6194-008)

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms